Chinese PLA General Hospital clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 2 with minor changes only.

1. Minor

   Different Cycles of Neoadjuvant PD-1 Blockades + Chemotherapy for…Different Cycles of Neoadjuvant PD-1 Blockades + Chemotherapy for Advanced Gastric Cancer

   Trial completed

   Also in this update: Final enrollment: 409 participants (planned 300); Primary completion date changed from estimate of Jan 31, 2025 to May 31, 2025

   Chinese PLA General Hospital·Not specified· NCT06798376· Registry history of NCT06798376 on ClinicalTrials.gov (opens the registry)

   Oct 15, 2026

2. Minor

   RC48-ADC Combined With S-1 for First-line Treatment of Advanced…RC48-ADC Combined With S-1 for First-line Treatment of Advanced Gastroesophageal Adenocarcinoma With Moderate Expression of HER2

   Registry marked status Unknown (sponsor has not verified the record since Jan 2024); last known: Recruiting

   Chinese PLA General Hospital·Phase 1/2· NCT05403242· Registry history of NCT05403242 on ClinicalTrials.gov (opens the registry)

   Changed Oct 4, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.